A detailed history of Abrdn PLC transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Abrdn PLC holds 87,578 shares of LH stock, worth $17.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
87,578
Previous 84,429 3.73%
Holding current value
$17.8 Million
Previous $19.2 Million 0.3%
% of portfolio
0.04%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$209.01 - $232.56 $658,172 - $732,331
3,149 Added 3.73%
87,578 $19.1 Million
Q4 2023

Jan 31, 2024

BUY
$197.69 - $227.29 $3.87 Million - $4.45 Million
19,557 Added 30.15%
84,429 $19.2 Million
Q3 2023

Nov 06, 2023

BUY
$201.05 - $221.7 $1.29 Million - $1.42 Million
6,403 Added 10.95%
64,872 $13 Million
Q2 2023

Jun 20, 2024

BUY
$211.93 - $241.33 $1.34 Million - $1.53 Million
6,334 Added 12.15%
58,469 $14.1 Million
Q2 2023

Aug 04, 2023

BUY
$211.93 - $241.33 $1.34 Million - $1.53 Million
6,334 Added 12.15%
58,469 $14.1 Million
Q1 2023

Jun 20, 2024

BUY
$213.32 - $257.83 $181,322 - $219,155
850 Added 1.66%
52,135 $12 Million
Q1 2023

Apr 28, 2023

BUY
$213.32 - $257.83 $181,322 - $219,155
850 Added 1.66%
52,135 $12 Million
Q4 2022

Jun 20, 2024

SELL
$203.72 - $248.97 $7.39 Million - $9.04 Million
-36,293 Reduced 41.44%
51,285 $12.1 Million
Q4 2022

Feb 09, 2023

BUY
$203.72 - $248.97 $402,550 - $491,964
1,976 Added 4.01%
51,285 $12.1 Million
Q3 2022

Nov 10, 2022

BUY
$204.81 - $262.19 $2.03 Million - $2.6 Million
9,908 Added 25.15%
49,309 $10.1 Million
Q2 2022

Aug 05, 2022

BUY
$213.86 - $277.87 $211,507 - $274,813
989 Added 2.57%
39,401 $9.27 Million
Q1 2022

May 04, 2022

SELL
$259.82 - $298.18 $3.59 Million - $4.11 Million
-13,799 Reduced 26.43%
38,412 $10.4 Million
Q4 2021

Feb 08, 2022

SELL
$271.6 - $314.21 $649,938 - $751,904
-2,393 Reduced 4.38%
52,211 $16.4 Million
Q3 2021

Nov 15, 2021

SELL
$274.82 - $308.34 $81,621 - $91,576
-297 Reduced 0.54%
54,604 $15.6 Million
Q2 2021

Aug 10, 2021

BUY
$251.87 - $278.14 $908,243 - $1 Million
3,606 Added 7.03%
54,901 $15.1 Million
Q1 2021

May 06, 2021

BUY
$204.88 - $255.03 $1.34 Million - $1.67 Million
6,543 Added 14.62%
51,295 $13.1 Million
Q4 2020

Feb 10, 2021

BUY
$186.91 - $214.42 $183,919 - $210,989
984 Added 2.25%
44,752 $9.11 Million
Q3 2020

Oct 21, 2020

SELL
$167.03 - $201.3 $946,224 - $1.14 Million
-5,665 Reduced 11.46%
43,768 $8.24 Million
Q2 2020

Aug 10, 2020

SELL
$113.31 - $182.44 $360,779 - $580,888
-3,184 Reduced 6.05%
49,433 $8.21 Million
Q1 2020

May 13, 2020

SELL
$104.32 - $195.28 $350,306 - $655,750
-3,358 Reduced 6.0%
52,617 $6.66 Million
Q4 2019

Feb 18, 2020

SELL
$163.48 - $173.61 $494,853 - $525,517
-3,027 Reduced 5.13%
55,975 $9.47 Million
Q3 2019

Nov 13, 2019

BUY
$159.77 - $178.1 $462,693 - $515,777
2,896 Added 5.16%
59,002 $9.91 Million
Q2 2019

Aug 13, 2019

SELL
$144.16 - $172.9 $154,683 - $185,521
-1,073 Reduced 1.88%
56,106 $9.7 Million
Q1 2019

May 14, 2019

BUY
$123.7 - $156.3 $1.98 Million - $2.5 Million
16,020 Added 38.92%
57,179 $8.75 Million
Q4 2018

Feb 12, 2019

SELL
$120.82 - $174.09 $126,861 - $182,794
-1,050 Reduced 2.49%
41,159 $5.13 Million
Q3 2018

Nov 13, 2018

BUY
$167.67 - $188.27 $487,416 - $547,300
2,907 Added 7.4%
42,209 $7.33 Million
Q2 2018

Aug 09, 2018

BUY
$160.33 - $189.41 $908,750 - $1.07 Million
5,668 Added 16.85%
39,302 $7.06 Million
Q1 2018

May 15, 2018

SELL
$161.53 - $178.11 $37,151 - $40,965
-230 Reduced 0.68%
33,634 $5.44 Million
Q4 2017

Feb 12, 2018

BUY
$147.99 - $163.95 $97,081 - $107,551
656 Added 1.98%
33,864 $5.4 Million
Q3 2017

Nov 14, 2017

BUY
$149.47 - $160.56 $4.96 Million - $5.33 Million
33,208
33,208 $5.01 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $18.2B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.